GSK Pays $2.6M To Exit Idaho Drug Price-Fixing Suit
GSK is one of several drugmakers targeted over inflated drug prices in lawsuits brought by state attorneys general across the country. The attorneys general say their states' Medicaid programs used drugmakers' allegedly inflated prices to calculate how much to reimburse pharmacies for prescription drugs.
An Idaho federal court has approved GSK's...
To view the full article, register now.